A team of researchers led by scientists at the University of California, Berkeley, has discovered how cysteine, an amino acid found in many proteins, activates a key regulator of cell growth in yeast. The findings, published in the journal Cell, could have implications for understanding and treating a variety of human diseases, including cancer and diabetes.

The researchers focused on a protein called TORC1, which is a central regulator of cell growth, metabolism, and aging. TORC1 is activated by a variety of nutrients, including glucose and amino acids. However, the mechanism by which cysteine activates TORC1 has been unclear.

The researchers found that cysteine activates TORC1 by binding to a specific site on the protein. This binding event causes TORC1 to undergo a conformational change that allows it to become active.

The researchers also found that cysteine activation of TORC1 is essential for cell growth in yeast. When cysteine is absent, yeast cells are unable to grow.

The findings could have implications for understanding and treating a variety of human diseases, including cancer and diabetes. TORC1 is a key regulator of cell growth and metabolism, and its dysregulation has been linked to a variety of diseases. By understanding how cysteine activates TORC1, researchers may be able to develop new treatments for these diseases.

Implications for Human Health

The findings of this study could have implications for understanding and treating a variety of human diseases, including cancer and diabetes.

Cancer

TORC1 is a key regulator of cell growth and metabolism, and its dysregulation has been linked to a variety of cancers. For example, TORC1 is overactive in many types of cancer, and this overactivity promotes cancer cell growth and survival. By understanding how cysteine activates TORC1, researchers may be able to develop new treatments for cancer that target TORC1.

Diabetes

TORC1 also plays a role in glucose metabolism, and its dysregulation has been linked to diabetes. For example, TORC1 is overactive in many people with type 2 diabetes, and this overactivity contributes to insulin resistance and high blood sugar levels. By understanding how cysteine activates TORC1, researchers may be able to develop new treatments for diabetes that target TORC1.

Conclusion

The findings of this study provide new insights into the regulation of TORC1, a key regulator of cell growth and metabolism. These findings could have implications for understanding and treating a variety of human diseases, including cancer and diabetes.